Skip Navigation


Human Molecular Genetics Advance Access originally published online on April 27, 2006
Human Molecular Genetics 2006 15(11):1894-1913; doi:10.1093/hmg/ddl112
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrowOA All Versions of this Article:
15/11/1894    most recent
ddl112v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (30)
Google Scholar
Right arrow Articles by Armstrong, L.
Right arrow Articles by Lako, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Armstrong, L.
Right arrow Articles by Lako, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited

The role of PI3K/AKT, MAPK/ERK and NF{kappa}ß signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis

Lyle Armstrong1,2,{dagger}, Owen Hughes1,2,{dagger}, Sun Yung1,2, Louise Hyslop1,2, Rebecca Stewart1,2, Ilka Wappler1,2, Heiko Peters1,2, Theresia Walter1,2, Petra Stojkovic1,2,{ddagger}, Jerome Evans2, Miodrag Stojkovic1,2,{ddagger} and Majlinda Lako1,2,*

1Centre for Stem Cell Biology and 2Developmental Genetics, Institute of Human Genetics, University of Newcastle, Newcastle upon Tyne, UK

* To whom correspondence should be addressed at: Centre for Stem Cell Biology and Developmental Genetics, Institute of Human Genetics, University of Newcastle upon Tyne, International Centre for Life, Central Parkways, Newcastle upon Tyne NE1 3BZ, UK. Tel: +44 1912418688; Fax: +44 1912418666; Email: majlinda.lako{at}ncl.ac.uk

Received January 16, 2006; Revised March 11, 2006; Accepted April 11, 2006

Understanding the molecular mechanism by which pluripotency is maintained in human embryonic stem cells (hESC) is important for the development of improved methods to derive, culture and differentiate these into cells of potential therapeutic use. Large-scale transcriptional comparison of the hES-NCL1 line derived from a day 8 embryo with H1 line derived from a day 5 embryo (WiCell Inc.) showed that only 0.52% of the transcripts analysed varied significantly between the two cell lines. This is within the variability range that has been reported when hESC derived from days 5–6 embryos have been compared with each other. This implies that transcriptional differences between the cell lines are likely to reflect their genetic profile rather than the embryonic stage from which they were derived. Bioinformatic analysis of expression changes observed when these cells were induced to differentiate as embryoid bodies suggested that quite a few of the downregulated genes were components of signal transduction networks. Subsequent analysis using western blotting, flow cytometry and antibody arrays implicated components of the PI3K/AKT kinase, MAPK/ERK and NF{kappa}ß pathways and confirmed that these components are decreased upon differentiation. Disruption of these pathways in isolation using specific inhibitors resulted in loss of pluripotency and/or loss of viability suggesting the importance of such signalling pathways in embryonic stem cell maintenance.

{dagger}The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.

{ddagger}Present address: Centro de Investigación Príncipe Felipe, Valencia, Spain.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Stem CellsHome page
C. Yang, S. Przyborski, M. J. Cooke, X. Zhang, R. Stewart, G. Anyfantis, S. P. Atkinson, G. Saretzki, L. Armstrong, and M. Lako
A Key Role for Telomerase Reverse Transcriptase Unit in Modulating Human Embryonic Stem Cell Proliferation, Cell Cycle Dynamics, and In Vitro Differentiation
Stem Cells, April 1, 2008; 26(4): 850 - 863.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
V. Fox, P. J. Gokhale, J. R. Walsh, M. Matin, M. Jones, and P. W. Andrews
Cell-Cell Signaling Through NOTCH Regulates Human Embryonic Stem Cell Proliferation
Stem Cells, March 1, 2008; 26(3): 715 - 723.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
G. Saretzki, T. Walter, S. Atkinson, J. F. Passos, B. Bareth, W. N. Keith, R. Stewart, S. Hoare, M. Stojkovic, L. Armstrong, et al.
Downregulation of Multiple Stress Defense Mechanisms During Differentiation of Human Embryonic Stem Cells
Stem Cells, February 1, 2008; 26(2): 455 - 464.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
L. Wang, T. C. Schulz, E. S. Sherrer, D. S. Dauphin, S. Shin, A. M. Nelson, C. B. Ware, M. Zhan, C.-Z. Song, X. Chen, et al.
Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling
Blood, December 1, 2007; 110(12): 4111 - 4119.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
B. Binetruy, L. Heasley, F. Bost, L. Caron, and M. Aouadi
Concise Review: Regulation of Embryonic Stem Cell Lineage Commitment by Mitogen-Activated Protein Kinases
Stem Cells, May 1, 2007; 25(5): 1090 - 1095.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
S. Ahmad, R. Stewart, S. Yung, S. Kolli, L. Armstrong, M. Stojkovic, F. Figueiredo, and M. Lako
Differentiation of Human Embryonic Stem Cells into Corneal Epithelial-Like Cells by In Vitro Replication of the Corneal Epithelial Stem Cell Niche
Stem Cells, May 1, 2007; 25(5): 1145 - 1155.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
S. Assou, T. Le Carrour, S. Tondeur, S. Strom, A. Gabelle, S. Marty, L. Nadal, V. Pantesco, T. Reme, J.-P. Hugnot, et al.
A Meta-Analysis of Human Embryonic Stem Cells Transcriptome Integrated into a Web-Based Expression Atlas
Stem Cells, April 1, 2007; 25(4): 961 - 973.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. P. Storm, H. K. Bone, C. G. Beck, P.-Y. Bourillot, V. Schreiber, T. Damiano, A. Nelson, P. Savatier, and M. J. Welham
Regulation of Nanog Expression by Phosphoinositide 3-Kinase-dependent Signaling in Murine Embryonic Stem Cells
J. Biol. Chem., March 2, 2007; 282(9): 6265 - 6273.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
H. Skottman and O. Hovatta
Culture conditions for human embryonic stem cells.
Reproduction, November 1, 2006; 132(5): 691 - 698.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.